Palm Rashes

Common features and patterns:

• Color:

1. Red or erythematous: Common in inflammatory or allergic reactions.
2. Purple or purpuric: May suggest vascular or hematologic issues, such as small blood vessel inflammation (vasculitis).
3. White or hypopigmented: Seen in fungal infections or depigmentation disorders.
4. Brown or hyperpigmented: May occur in chronic skin conditions or post-inflammatory hyperpigmentation.

• Texture:

1. Flat (macular): Rash appears as flat, discolored spots.
2. Raised (papular or nodular): Bumps that may be small or large.
3. Scaly or flaky: Seen in psoriasis or fungal infections.
4. Smooth or shiny: Can occur in viral rashes or early dermatitis.

• Moisture:

1. Dry and cracked: Common in eczema or chronic irritation.
2. Moist or oozing: May suggest infection, blistering, or acute contact dermatitis.

• Distribution:

1. Symmetrical: Seen in systemic causes like eczema, psoriasis, or drug reactions.
2. Localized: Often indicates contact dermatitis or insect bites.
3. Peripheral patterns: Rashes that concentrate around the edges of the palms can be seen in certain fungal infections.

• Associated Symptoms:

1. Itching: Common in eczema, scabies, or allergic reactions.
2. Pain or burning: Suggests irritation, infection, or vascular issues.
3. Blisters: Seen in contact dermatitis, hand-foot-and-mouth disease, or bullous skin conditions.
4. Peeling or desquamation: Seen after infections (e.g., scarlet fever) or in conditions like Kawasaki disease.

• Causes & Features:

1. Contact Dermatitis: Red, itchy patches, sometimes with vesicles or blisters.
2. Atopic Dermatitis: Chronic, itchy, scaly rash; may worsen with exposure to irritants.
3. Psoriasis: Thick, scaly, silvery patches, often with well-defined edges.
4. Hand-Foot-and-Mouth Disease: Small, red spots or blisters on palms, soles, and sometimes around the mouth.
5. Fungal Infections (Tinea Manuum): Asymmetric scaling and redness, often with peeling.
6. Scabies: Small, red papules with linear burrows, typically between fingers.
7. Drug Reactions: Diffuse rash that can affect the palms, often accompanied by systemic symptoms.

 

Infographics

Tremor

1. Involuntary, rhythmic, shaking movement of part of the body
2. Occur when muscles repeatedly contract and relax.
3. Classification:

• Physiologic (Normal)
• Abnormal (Pathologic)
• Essential (Hereditary disorder)
• Cerebellar (Damage to cerebellum)
• Secondary (medication, or substance use, etc.)
• Psychogenic (Psychologic factors)

Infographics

Chronic Kidney Disease (CKD)

 

Blood pressure–lowering therapy and treatment targets should be individualized in patients with frailty, a high risk of falls, very limited life expectancy, or symptomatic postural hypotension.

Therapies with strong evidence for delaying chronic kidney disease (CKD) progression include renin–angiotensin system inhibitors (RASi) and sodium–glucose cotransporter 2 inhibitors (SGLT2i). In patients with CKD and heart failure, SGLT2i provide benefits regardless of albuminuria status.

A modest initial decline in estimated glomerular filtration rate (eGFR) is expected following the initiation of hemodynamically active agents such as RASi and SGLT2i. However, a reduction in eGFR of ≥30% from baseline exceeds anticipated variability and should prompt further evaluation.

CKD is not a contraindication to invasive management strategies in patients with acute or unstable cardiac conditions. Similarly, imaging studies are not absolutely contraindicated in patients with CKD; the decision should be based on a careful assessment of individual risks and benefits.

Infographics

Radio-opaque shadows on ABDOMINAL X-RAY

• A substance is more radiopaque if it contains atoms of high atomic number (AN) such as calcium, iodine, barium, or lead.
• Bone, which contains calcium (AN 20), is more radiopaque than soft tissue, which is made up mostly of carbon (AN 6), hydrogen (AN 1), and oxygen (AN 8). 
• Iodine (AN 53) is the key constituent of radiocontrast material and lead (AN 82) is an effective barrier to x-rays.

Infographics

What Do You See

The eye is a highly complex organ composed of various tissues and structures that function together to enable vision. Ocular disorders can range from benign, self-limiting conditions to malignant, potentially metastatic tumors. A wide array of factors can contribute to eye diseases, leading to a spectrum of signs and symptoms. These symptoms may be as mild as minor irritation or discomfort, or as severe as blurred vision or complete blindness. One example of an ocular disorder is strabismus, a condition characterized by misalignment of the eyes. In strabismus, one eye typically fixates on an object of interest while the other deviates inward (esotropia), outward (exotropia), downward (hypotropia), or upward (hypertropia).

Infographics

Management of DM in Patients With CKD

Monitor blood pressure, serum creatinine, and serum potassium levels within 2 to 4 weeks after initiating or increasing the dose of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB). ACEi or ARB therapy should generally be continued unless serum creatinine increases by more than 30% within 4 weeks of initiation or dose escalation.

According to FDA recommendations, metformin should not be used in men with a serum creatinine level ≥ 1.5 mg/dL or in women with a level ≥ 1.4 mg/dL, or in individuals over 80 years of age with decreased creatinine clearance. However, treatment with metformin is recommended in patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m².

ADA/KDIGO Consensus Statements:

All patients with type 1 or type 2 diabetes and CKD should be managed using a comprehensive, individualized care plan developed collaboratively between healthcare professionals and the patient. This plan should focus on optimizing nutrition, physical activity, smoking cessation, and weight management. Evidence-based pharmacologic therapies should be implemented to preserve organ function, alongside additional treatments aimed at achieving intermediate targets for glycemic control, blood pressure, and lipid management.

Infographics